Literature DB >> 23553809

Cost and quality implications of opioid-based postsurgical pain control using administrative claims data from a large health system: opioid-related adverse events and their impact on clinical and economic outcomes.

E Richard Kessler1, Manan Shah, Stephen K Gruschkus, Aditya Raju.   

Abstract

STUDY
OBJECTIVE: To determine the prevalence of postsurgical opioid use in the inpatient setting, to ascertain the frequency of and risk factors for opioid-related adverse drug events (ORADEs) among patients who received opioids, and to evaluate the impact of ORADEs on clinical and economic outcomes.
DESIGN: Retrospective cohort study using administrative data.
SETTING: Hospital system encompassing 26 hospitals in the southeastern United States. PATIENTS: A total of 37,031 patients aged 18 years or older who underwent a common surgical procedure between January 1, 2009, and December 31, 2010.
MEASUREMENTS AND MAIN RESULTS: Patients were evaluated for receipt of postsurgical opioids. Outcomes among opioid users included ORADE rates, hospital length of stay, total hospitalization costs, 30-day readmission rates, outlier status, and inpatient mortality. Factors associated with ORADEs were evaluated; length of stay, costs, readmissions, and mortality were compared between patients experiencing and not experiencing ORADEs by using propensity score matching on age, race-ethnicity, sex, presurgery opioid use, and comorbidities. Length of stay and cost rate ratios were generated by using negative binomial regression and generalized linear models. Odds ratios for 30-day readmissions and inpatient mortality were generated by using logistic regression. Among all surgical patients, 36,529 (98.6%) of patients received opioids, of whom 4955 (13.6%) experienced an ORADE. Increased risk of ORADEs was associated with age 65 years or older, male sex, obesity, presurgery opioid use, and higher score on Charlson Comorbidity Index. Patients with an ORADE had a 55% longer length of stay, 47% higher costs of care, 36% increased risk of 30-day readmission, and 3.4 times higher risk of inpatient mortality than did patients who did not experience an ORADE.
CONCLUSION: Opioid use was ubiquitous among hospitalized patients who underwent common surgical procedures. The observed negative outcomes of ORADEs and their impact on patients and the health care system should be considered when evaluating the balance between effectively managing postsurgical pain while minimizing the risk of ORADEs.
© 2013 Pharmacotherapy Publications, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23553809     DOI: 10.1002/phar.1223

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  70 in total

1.  Improving the Safety of Opioid Use for Acute Noncancer Pain in Hospitalized Adults: A Consensus Statement From the Society of Hospital Medicine.

Authors:  Shoshana J Herzig; Hilary J Mosher; Susan L Calcaterra; Anupam B Jena; Teryl K Nuckols
Journal:  J Hosp Med       Date:  2018-04       Impact factor: 2.960

2.  Evaluation of a Long-Acting Opioid Restriction Policy: Does Restriction Reduce the Need for Naloxone Reversal?

Authors:  Jenna L Fancher; Robert W Seabury; William Darko; Luke A Probst; Christopher D Miller
Journal:  Hosp Pharm       Date:  2018-12-05

3.  Association of Opioid-Related Adverse Drug Events With Clinical and Cost Outcomes Among Surgical Patients in a Large Integrated Health Care Delivery System.

Authors:  Shahid Shafi; Ashley W Collinsworth; Laurel A Copeland; Gerald O Ogola; Taoran Qiu; Maria Kouznetsova; I-Chia Liao; Natalie Mears; An T Pham; George J Wan; Andrew L Masica
Journal:  JAMA Surg       Date:  2018-08-01       Impact factor: 14.766

4.  Goals and Objectives to Optimize the Value of an Acute Pain Service in Perioperative Pain Management.

Authors:  Linda Le-Wendling; Wesley Glick; Patrick Tighe
Journal:  Tech Orthop       Date:  2017-12

5.  Chronic Opioid Usage in Surgical Patients in a Large Academic Center.

Authors:  Xueying Jiang; Margaret Orton; Rui Feng; Erik Hossain; Neil R Malhotra; Eric L Zager; Renyu Liu
Journal:  Ann Surg       Date:  2017-04       Impact factor: 12.969

6.  Economic burden of opioid-induced constipation among long-term opioid users with noncancer pain.

Authors:  Yin Wan; Shelby Corman; Xin Gao; Sizhu Liu; Haridarshan Patel; Reema Mody
Journal:  Am Health Drug Benefits       Date:  2015-04

7.  Response to "bupivacaine liposomal versus bupivacaine: comparative review".

Authors:  E Richard Kessler
Journal:  Hosp Pharm       Date:  2014-10

8.  Commentary on: The Opioid Epidemic: Who Is Responsible and What Is the Solution?

Authors:  Warren Schubert
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2018-05-15

9.  Reduced Opioid Prescription Practices and Duration of Stay after TAP Block for Laparoscopic Appendectomy.

Authors:  Matthew C Hernandez; Eric J Finnesgard; Johnathon M Aho; Martin D Zielinski; Henry J Schiller
Journal:  J Gastrointest Surg       Date:  2019-01-22       Impact factor: 3.452

10.  Long-Term Trends in Postoperative Opioid Prescribing, 1994 to 2014.

Authors:  Catherine L Chen; Molly Moore Jeffery; Erin E Krebs; Cornelius A Thiels; Mark A Schumacher; Adam J Schwartz; Robert Thombley; Emily Finlayson; Rosa Rodriguez-Monguio; Derek Ward; R Adams Dudley
Journal:  J Am Acad Orthop Surg Glob Res Rev       Date:  2020-01-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.